FINAXIONResearch
Finaxion Research · Supertrend: the line that changes colour · single stocks · Recomputed 2026-09-10

Does Supertrend: the line that changes colour work on PSKY?

Supertrend: the line that changes colour beats buy-and-hold on PSKY by +15.3 points a year over 21 years.

Total return
×13
Buy and hold
-34.8%
CAGR
13.3%
Sharpe
0.42
Max drawdown
-68.0%
Trades
17
Out of sample
overfit
Years
21
1×10×22×20062008201020122014201620182020202220242026
StrategyPSKY

Findings

  1. Supertrend: the line that changes colour beats buy-and-hold on PSKY by +15.3 points a year over 21 years.
  2. Against the S&P 500 over the same window: +2.2 points a year.
  3. Total return ×13 versus -34.8% for buy-and-hold, with 17 trades.
  4. The result does not hold out of sample: it is overfit.
  5. Maximum drawdown -68.0%.
  6. It beats in both halves of the history (split at 2016).
  7. It ranks #38 of 235 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact e097c9613211.

Exactly what was tested

Entry when the close exceeds the upper band (ATR 10, multiplier 3); exit when the close drops below the lower band. The classic Supertrend definition.

How to read it

The verdict compares the strategy with buying and holding PSKY over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on PSKY → · Full page for Supertrend: the line that changes colour →

How to cite

Finaxion Research (2026). Does Supertrend: the line that changes colour work on PSKY?. Daily backtest 1962-01-01–2026-08-31, artifact e097c9613211. https://finaxion.app/en/research/supertrend/psky

Not a recommendation. Past performance does not guarantee future results.